Science Explorer Back to mapMap

Most cited papers from AVEO Oncology (United States)

What are the most cited papers from AVEO Oncology (United States)?

The most cited paper from AVEO Oncology (United States) is "Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019" (Jonathan Kocarnik et al., 2021), with 2,100 citations. Next come "Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells" (1,198) and "A conserved dendritic-cell regulatory program limits antitumour immunity" (978).

Showing 50 of 60 papers. Every paper with more than 106 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 Jonathan Kocarnik et al. · JAMA Oncology Open access601 authors 30 Dec 2021 2,100
2 Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells Jose Maria Polo, Susanna X. Liu, María E. Figueroa et al. · Nature Biotechnology Open access 19 Jul 2010 1,198
3 A conserved dendritic-cell regulatory program limits antitumour immunity Barbara B. Maier et al. · Nature Open access 25 Mar 2020 978
4 A guide to cell death pathways Junying Yuan, Dimitry Ofengeim · Nature Reviews Molecular Cell Biology Review 18 Dec 2023 918
5 Individual intestinal symbionts induce a distinct population of RORγ + regulatory T cells Esen Sefik, Naama Geva‐Zatorsky, Sungwhan F. Oh et al. · Science Open access 13 Aug 2015 903
6 The complex role of tumor-infiltrating macrophages Anthos Christofides, Laura Strauss, Alan T. Yeo et al. · Nature Immunology Open access 25 Jul 2022 877
7 Tim‐3 and its role in regulating anti‐tumor immunity Madhumita Das, Chen Ying Zhu, Vijay Kumar Kuchroo · Immunological Reviews ReviewOpen access Mar 2017 874
8 A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation Xin Zeng, Keiko Tamai, Bradley W. Doble et al. · Nature Open access Dec 2005 866
9 Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study Michel Attal et al. · The Lancet 130 authors 14 Nov 2019 648
10 Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression Guocan Wang et al. · Cancer Discovery Open access 23 Dec 2015 568
11 Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress Kathrin Zaugg et al. · Genes & Development Open access 15 May 2011 509
12 Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Mohsen Naghavi et al. · The Lancet Open access2,463 authors Oct 2025 500
13 The Role of the Anesthesiologist in Fast-Track Surgery: From Multimodal Analgesia to Perioperative Medical Care Paul F. White, Henrik Kehlet, Joseph M. Neal et al. · Anesthesia & Analgesia 15 May 2007 485
14 Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t Marjolein S. de Bruin-Weller, Diamant Thaçi, Catherine Smith et al. · British Journal of Dermatology Open access 29 Nov 2017 478
15 Natural killer cell therapies Eric D. Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli et al. · Nature 21 Feb 2024 466
16 Applications of single-cell RNA sequencing in drug discovery and development Bram Van de Sande, Joon Sang Lee, Euphemia Mutasa-Gottgens et al. · Nature Reviews Drug Discovery ReviewOpen access 28 Apr 2023 455
17 A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT Yousang Gwack, Sonia Sharma, Julie Nardone et al. · Nature Mar 2006 401
18 Apoptotic cell death in disease—Current understanding of the NCCD 2023 Ilio Vitale et al. · Cell Death and Differentiation Open access228 authors 26 Apr 2023 376
19 MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration Carolina Cebrián, Fabio Andrea Zucca, Pierluigi Mauri et al. · Nature Communications Open access 16 Apr 2014 347
20 SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells Yuelong Yan, Hongqi Teng, Qinglei Hang et al. · Nature Communications Open access 21 Jun 2023 344
21 Next-generation influenza vaccines: opportunities and challenges Chih‐Jen Wei, Michelle C. Crank, John W. Shiver et al. · Nature Reviews Drug Discovery ReviewOpen access 14 Feb 2020 344
22 NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021 Susan M. Swetter et al. · Journal of the National Comprehensive Cancer Network Apr 2021 341
23 Implementation of an Atmosphere–Ocean General Circulation Model on the Expanded Spherical Cube Alistair Adcroft, Jean‐Michel Campin, Chris N. Hill et al. · Monthly Weather Review Open access Dec 2004 336
24 Caenorhabditis elegans SID-2 is required for environmental RNA interference William M. Winston, Marie E. Sutherlin, Amanda J. Wright et al. · Proceedings of the National Academy of Sciences Open access 12 Jun 2007 327
25 Development and Validation of a Dutch Translation of the Big Five Inventory (BFI) Jaap J. A. Denissen, Rinie Geenen, Marcel A. G. van Aken et al. · Journal of Personality Assessment 25 Feb 2008 311
26 Body Roundness Index and All-Cause Mortality Among US Adults Xiaoqian Zhang, Nan Ma, Qiushi Lin et al. · JAMA Network Open Open access 5 Jun 2024 309
27 NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022 Thomas W. Flaig et al. · Journal of the National Comprehensive Cancer Network Open access Aug 2022 309
28 Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques Ling Xu et al. · Science Open access 20 Sep 2017 277
29 Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study Brian I. Rini, Sumanta Kumar Pal, Bernard J. Escudier et al. · The Lancet Oncology 3 Dec 2019 266
30 Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the E uropean U nion Odile Moulard, Jyotsna Mehta, Jon P. Fryzek et al. · European Journal Of Haematology 24 Dec 2013 264
31 Epidemiology of myeloproliferative neoplasms in the United States Jyotsna Mehta, Hongwei Wang, Sheikh Usman Iqbal et al. · Leukemia & lymphoma/Leukemia and lymphoma 14 Jun 2013 253
32 Challenges to capture the big five personality traits in non-WEIRD populations Rachid Laajaj, Karen Macours, Daniel Alejandro Pinzon Hernandez et al. · Science Advances Open access 5 Jul 2019 232
33 Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer Elizabeth A. Buck, Prafulla C. Gokhale, Susan Koujak et al. · Molecular Cancer Therapeutics Oct 2010 220
34 Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models Christian Hotz et al. · Science Translational Medicine 8 Sep 2021 216
35 Activation of platelet phosphatidylinositide 3-kinase requires the small GTP-binding protein Rho. Jin Chi Zhang, Warren G. King, Simon T. Dillon et al. · Journal of Biological Chemistry Open access Oct 1993 212
36 Use of precision cut lung slices as a translational model for the study of lung biology Guanghui Liu, Catherine Jean Betts, Danen Mootoosamy Cunoosamy et al. · Respiratory Research Open access 19 Jul 2019 210
37 Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients Lorena R. Lerner, Teresa Gray Hayes, Nianjun Tao et al. · Journal of Cachexia Sarcopenia and Muscle Open access 30 Apr 2015 208
38 Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases Guillermo Barturen et al. · Arthritis & Rheumatology Open access132 authors 8 Dec 2020 196
39 MAP3K11/GDF15 axis is a critical driver of cancer cachexia Lorena R. Lerner, Julie Tao, Qing H. Liu et al. · Journal of Cachexia Sarcopenia and Muscle Open access 29 Oct 2015 188
40 Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion Katharine D. Grugan, Charles G. Miller, Yao Yao et al. · Proceedings of the National Academy of Sciences Open access Jun 2010 185
41 Non-germline genetically engineered mouse models for translational cancer research Joerg Heyer, Lawrence N. Kwong, Scott W. Lowe et al. · Nature reviews. Cancer ReviewOpen access 24 Jun 2010 181
42 Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab Thomas G. Martin, Kathryn P. Corzo, Marielle Chiron et al. · Cells Open access 26 Nov 2019 166
43 A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells Edward Seung et al. · Nature 23 Feb 2022 163
44 Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities Mariella G. Filbin et al. · Nature Medicine Open access 29 Sep 2013 153
45 GP369, an FGFR2-IIIb–Specific Antibody, Exhibits Potent Antitumor Activity against Human Cancers Driven by Activated FGFR2 Signaling Ailin Bai, Kristan A. Meetze, Nhi Ngoc Y Vo et al. · Cancer Research 13 Aug 2010 151
46 MET Signaling in Colon Cancer Stem-like Cells Blunts the Therapeutic Response to EGFR Inhibitors Paolo Luraghi, Gigliola Reato, Élia Cipriano et al. · Cancer Research Open access 21 Jan 2014 147
47 Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study Balázs Ács, Vasiliki Pelekanou, Yalai Bai et al. · Laboratory Investigation Open access 4 Sep 2018 142
48 Enabling Ideal Selective Solar Absorption with 2D Metallic Dielectric Photonic Crystals Jeffrey B. Chou, Yi Xiang Yeng, Yoonkyung E. Lee et al. · Advanced Materials Open access 16 Sep 2014 141
49 Selective Inhibition of Mutant Isocitrate Dehydrogenase 1 (IDH1) via Disruption of a Metal Binding Network by an Allosteric Small Molecule Gejing Deng et al. · Journal of Biological Chemistry Open access 13 Nov 2014 139
50 Human XCR1+ Dendritic Cells Derived In Vitro from CD34+ Progenitors Closely Resemble Blood Dendritic Cells, Including Their Adjuvant Responsiveness, Contrary to Monocyte-Derived Dendritic Cells Sreekumar Balan et al. · The Journal of Immunology Open access 10 Jul 2014 136

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.